ID

23147

Beschreibung

Clinical Trial of Recombinant Hepatitis E Vaccine; ODM derived from: https://clinicaltrials.gov/show/NCT01014845

Link

https://clinicaltrials.gov/show/NCT01014845

Stichworte

  1. 26.06.17 26.06.17 -
Hochgeladen am

26. Juni 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hepatitis E NCT01014845

Eligibility Hepatitis E NCT01014845

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
healthy people aged from 16 years to 65 years old at the time of the first vaccination, normal intelligence and agree to sign the informed consent form.
Beschreibung

ID.1

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C0424576
UMLS CUI [1,3]
C1168057
UMLS CUI [1,4]
C0021430
subjects will reside in the study region in the next 19 months.
Beschreibung

ID.2

Datentyp

boolean

Alias
UMLS CUI [1]
C1550511
free of history of hepatitis b or hepatitis e.
Beschreibung

ID.3

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332122
UMLS CUI [1,2]
C0019163
UMLS CUI [1,3]
C0085293
can comply with the request of study.
Beschreibung

ID.4

Datentyp

boolean

Alias
UMLS CUI [1]
C1321605
axillary temperature is below 37 degree centigrade.
Beschreibung

ID.5

Datentyp

boolean

Alias
UMLS CUI [1]
C1531924
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
having other vaccine or immunoglobulin within two weeks;
Beschreibung

ID.7

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0042196
UMLS CUI [1,2]
C0021027
having allergic history to vaccine and medicine
Beschreibung

ID.8

Datentyp

boolean

Alias
UMLS CUI [1]
C0571550
eclampsia, epilepsy, encephalopathy and history of mental disease or family;
Beschreibung

ID.9

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0013537
UMLS CUI [1,3]
C0014544
UMLS CUI [1,4]
C0085584
thrombocytopenia or other disturbance of blood coagulation which would lead to muscle injection taboo;
Beschreibung

ID.10

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0040034
UMLS CUI [1,2]
C0005779
fixed or suspected deficiency of immunologic function, containing immunosuppressant treatment(radiation therapy, chemical treatment, steroid hormone, antimetabolites, cytotoxic drugs), genetic defect(e.g. fabism), hiv or other factors;
Beschreibung

ID.11

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C0021051
congenital malformation, eccyliosis or severe chronic disease(e.g. down syndrome, diabetes, sickle cell anemia or mental disease);
Beschreibung

ID.12

Datentyp

boolean

Alias
UMLS CUI [1]
C0012634
fixed or suspected other disease including fever, active infection, liver and kidney disease, angiocardiopathy, malignancy, acute and chronic disease;
Beschreibung

ID.13

Datentyp

boolean

Alias
UMLS CUI [1]
C0012634
joining other clinical study undergoing;
Beschreibung

ID.14

Datentyp

boolean

Alias
UMLS CUI [1]
C0008976
women pregnant or in lactation.
Beschreibung

ID.15

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
severe allergy for dose 1 or 2;
Beschreibung

ID.17

Datentyp

boolean

Alias
UMLS CUI [1]
C0020517
severe adverse reaction associated with last vaccination;
Beschreibung

ID.18

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0559546
UMLS CUI [1,2]
C0042196

Ähnliche Modelle

Eligibility Hepatitis E NCT01014845

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
healthy people aged from 16 years to 65 years old at the time of the first vaccination, normal intelligence and agree to sign the informed consent form.
boolean
C0001779 (UMLS CUI [1,1])
C0424576 (UMLS CUI [1,2])
C1168057 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,4])
ID.2
Item
subjects will reside in the study region in the next 19 months.
boolean
C1550511 (UMLS CUI [1])
ID.3
Item
free of history of hepatitis b or hepatitis e.
boolean
C0332122 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
C0085293 (UMLS CUI [1,3])
ID.4
Item
can comply with the request of study.
boolean
C1321605 (UMLS CUI [1])
ID.5
Item
axillary temperature is below 37 degree centigrade.
boolean
C1531924 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.7
Item
having other vaccine or immunoglobulin within two weeks;
boolean
C0042196 (UMLS CUI [1,1])
C0021027 (UMLS CUI [1,2])
ID.8
Item
having allergic history to vaccine and medicine
boolean
C0571550 (UMLS CUI [1])
ID.9
Item
eclampsia, epilepsy, encephalopathy and history of mental disease or family;
boolean
C0004936 (UMLS CUI [1,1])
C0013537 (UMLS CUI [1,2])
C0014544 (UMLS CUI [1,3])
C0085584 (UMLS CUI [1,4])
ID.10
Item
thrombocytopenia or other disturbance of blood coagulation which would lead to muscle injection taboo;
boolean
C0040034 (UMLS CUI [1,1])
C0005779 (UMLS CUI [1,2])
ID.11
Item
fixed or suspected deficiency of immunologic function, containing immunosuppressant treatment(radiation therapy, chemical treatment, steroid hormone, antimetabolites, cytotoxic drugs), genetic defect(e.g. fabism), hiv or other factors;
boolean
C0021081 (UMLS CUI [1,1])
C0021051 (UMLS CUI [1,2])
ID.12
Item
congenital malformation, eccyliosis or severe chronic disease(e.g. down syndrome, diabetes, sickle cell anemia or mental disease);
boolean
C0012634 (UMLS CUI [1])
ID.13
Item
fixed or suspected other disease including fever, active infection, liver and kidney disease, angiocardiopathy, malignancy, acute and chronic disease;
boolean
C0012634 (UMLS CUI [1])
ID.14
Item
joining other clinical study undergoing;
boolean
C0008976 (UMLS CUI [1])
ID.15
Item
women pregnant or in lactation.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
ID.17
Item
severe allergy for dose 1 or 2;
boolean
C0020517 (UMLS CUI [1])
ID.18
Item
severe adverse reaction associated with last vaccination;
boolean
C0559546 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video